Log in to save to my catalogue

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of...

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7463008

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

About this item

Full title

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2020-09, Vol.10 (8), p.90-90, Article 90

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In AL amyloidosis complete response (aCR) is defined as negative serum and urine immunofixation with normalized free light chain ratio (FLCR). However, achievement of low levels of involved FLC (iFLC) or difference between iFLC and uninvolved FLC (dFLC) are also relevant endpoints for treatment. We divided 434 consecutive patients with AL amyloidos...

Alternative Titles

Full title

Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7463008

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7463008

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-020-00355-6

How to access this item